MT2014-25: Haplo NK With SQ IL-15 in Adult Relapsed or Refractory AML Patients
Clinical trial NCT02395822 · COMPLETED
Trial details
- NCT number
- NCT02395822
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2016-12-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.